| Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease SM Bloom, VN Bijanki, GM Nava, L Sun, NP Malvin, DL Donermeyer, ... Cell host & microbe 9 (5), 390-403, 2011 | 517 | 2011 |
| The microbial metabolite desaminotyrosine protects from influenza through type I interferon AL Steed, GP Christophi, GE Kaiko, L Sun, VM Goodwin, U Jain, ... Science 357 (6350), 498-502, 2017 | 455 | 2017 |
| Type I interferons link viral infection to enhanced epithelial turnover and repair L Sun, H Miyoshi, S Origanti, TJ Nice, AC Barger, NA Manieri, LA Fogel, ... Cell host & microbe 17 (1), 85-97, 2015 | 92 | 2015 |
| Host genetic susceptibility, dysbiosis, and viral triggers in inflammatory bowel disease L Sun, GM Nava, TS Stappenbeck Current opinion in gastroenterology 27 (4), 321-327, 2011 | 84 | 2011 |
| Novel mode of ISG15-mediated protection against influenza A virus and Sendai virus in mice DJ Morales, K Monte, L Sun, JJ Struckhoff, E Agapov, MJ Holtzman, ... Journal of virology 89 (1), 337-349, 2015 | 43 | 2015 |
| Deep learning quantification of percent steatosis in donor liver biopsy frozen sections L Sun, JN Marsh, MK Matlock, L Chen, JP Gaut, EM Brunt, SJ Swamidass, ... EBioMedicine 60, 2020 | 34 | 2020 |
| High-risk gastric pathology and prevalent autoimmune diseases in patients with pernicious anemia JW Hughes, BD Muegge, GS Tobin, M Litvin, L Sun, JB Saenz, ... Endocrine Practice 23 (11), 1297-1303, 2017 | 23 | 2017 |
| Molecular testing in breast cancer: Current status and future directions L Sun, A Wu, GR Bean, IS Hagemann, CY Lin The Journal of Molecular Diagnostics 23 (11), 1422-1432, 2021 | 20 | 2021 |
| Pitfalls in molecular diagnostics L Sun, JD Pfeifer Seminars in Diagnostic Pathology 36 (5), 342-354, 2019 | 15 | 2019 |
| UV signature mutations reclassify salivary high-grade neuroendocrine carcinomas as occult metastatic cutaneous merkel cell carcinomas L Sun, PF Cliften, EJ Duncavage, JS Lewis Jr, RD Chernock The American Journal of Surgical Pathology 43 (5), 682-687, 2019 | 15 | 2019 |
| Clinical decision support for ovarian carcinoma subtype classification: a pilot observer study with pathology trainees MA Gavrielides, M Miller, IS Hagemann, H Abdelal, Z Alipour, JF Chen, ... Archives of Pathology & Laboratory Medicine 144 (7), 869-877, 2020 | 11 | 2020 |
| RAD51 foci as a biomarker predictive of platinum chemotherapy response in ovarian cancer AJ Compadre, LN van Biljon, MC Valentine, A Llop-Guevara, E Graham, ... Clinical Cancer Research 29 (13), 2466-2479, 2023 | 7 | 2023 |
| Comparison of gene fusion detection methods in salivary gland tumors L Sun, JS Petrone, SN McNulty, MJ Evenson, X Zhu, JA Robinson, ... Human Pathology 123, 1-10, 2022 | 7 | 2022 |
| SCCA1/SERPINB3 suppresses antitumor immunity and blunts therapy-induced T cell responses via STAT-dependent chemokine production L Chen, V Shi, S Wang, L Sun, R Freeman, J Yang, MJ Inkman, S Ghosh, ... The Journal of Clinical Investigation 133 (15), 2023 | 6 | 2023 |
| Clinicopathologic and molecular features of six cases of phosphaturic mesenchymal tumor L Sun, C Dehner, J Kenney, SM McNulty, X Zhu, JD Pfeifer, HM Maluf, ... Virchows Archiv 478, 757-765, 2021 | 6 | 2021 |
| Clinical implications of a targeted RNA-sequencing panel in the detection of gene fusions in solid tumors L Sun, SN McNulty, MJ Evenson, X Zhu, JA Robinson, PR Mann, ... The Journal of Molecular Diagnostics 23 (12), 1749-1760, 2021 | 5 | 2021 |
| Identification of novel ALK rearrangements in gynecologic clear cell carcinoma C Yang, L Zhang, L Love‐Gregory, L Sun, IS Hagemann, D Cao International Journal of Cancer 148 (2), 459-468, 2021 | 5 | 2021 |
| Expression of potential biomarker targets by immunohistochemistry in cervical carcinomas L Sun, MC Schroeder, IS Hagemann, JD Pfeifer, JK Schwarz, PW Grigsby, ... International Journal of Gynecological Pathology 41 (6), 628-635, 2022 | 4 | 2022 |
| p16 immunohistochemistry is not always required for accurate diagnosis of grade 2 squamous intraepithelial lesions L Sun, L Zhang, HR Krigman, IS Hagemann Journal of lower genital tract disease 22 (2), 104-109, 2018 | 4 | 2018 |
| Type II endometrial cancers with minimal, non-invasive residual disease on final pathology: What should we do next? KA Mills, H Lopez, L Sun, JC Cripe, T Litz, PH Thaker, MA Powell, ... Gynecologic Oncology Reports 29, 20-24, 2019 | 2 | 2019 |
